US Stocks
/
Editas Medicine, Inc. Share Price
Editas Medicine, Inc. Share Price

Editas Medicine, Inc. Share Price

NASDAQ: EDIT | Micro Cap
$2.90
+$0.03 (1.22%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Editas Medicine, Inc. Stock Performance

Open
$2.84
Prev. Close
$2.87
Circuit Range
N/A
Day Range
$2.73 - $2.97
Year Range
$1.66 - $4.33
Volume
1,70,433
Average Traded
$2.90

Editas Medicine, Inc. Share Price Today

As of 10 October 2026, Editas Medicine, Inc.'s share price is $2.90. The stock opened at $2.84, compared to its previous close of $2.87. During today's trading session, Editas Medicine, Inc.'s share price traded between $2.73 and $2.97, with an average price of $2.85. Over the past 52 weeks, the stock has recorded a high of $4.33 and a low of $1.66. In terms of performance, Editas Medicine, Inc.'s share price has declined by 3.33% over the last six months and is down 5.54% on a year-on-year basis.

Editas Medicine, Inc. Share Price Chart

$2.73$2.97
L
Show Current Price
H

Editas Medicine, Inc. Stock Fundamentals & Key Indicators

Market Cap
$257.36M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$40.52B
Return On Equity (TTM)
-70.24%
Profit Margin
-395.01%
Debt to Equity
0.53
Quarterly Earnings Growth YoY
27.43%

Editas Medicine, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$7.54$24.74$2.83$11.89
Net Profit-$25.12-$5.62-$24.98-$18.23
Net Profit Margin-333.16%-22.72%-882.69%-153.32%
Income ChangeN/A77.63%-344.48%27.02%

Editas Medicine, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$19.71$78.12$32.31$40.52
Net Profit-$220.43-$153.22-$237.09-$160.06
Net Profit Margin-1118.37%-196.13%-733.80%-395.01%
Income ChangeN/A30.49%-54.74%32.49%

About Editas Medicine, Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Editas Medicine, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.61
$2.88
+12.04%
Sep 2026
$3.02
$2.58
-21.97%
Aug 2026
$2.58
$3.30
+28.40%
Jul 2026
$3.33
$2.57
-20.56%
Jun 2026
$3.33
$3.23
-6.37%
May 2026
$2.98
$3.46
+15.17%
Apr 2026
$2.61
$3.00
+21.21%
Mar 2026
$2.10
$2.48
+12.24%
Feb 2026
$1.98
$2.21
+11.36%
Jan 2026
$2.07
$1.98
-3.65%
Dec 2025
$2.36
$2.06
-14.37%
Nov 2025
$3.02
$2.40
-21.82%

EDIT Share Price FAQs

What is Editas Medicine, Inc. share price today?

chevron-up
Editas Medicine, Inc. share price today is $2.90 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Editas Medicine, Inc. stock?

chevron-up
The 52 week high of Editas Medicine, Inc. stock is $4.33, while the 52 week low is $1.66 as of 10 Oct '26.

What is EDIT's market capitalisation today?

chevron-up
EDIT market capitalisation is $257.36M as of October 10, 2026, at 4:40 am IST.

What is EDIT's net income for the last quarter?

chevron-up
EDIT's net income for the last quarter is -18.23B USD.

What is the 5 year returns of EDIT?

chevron-up
The 5 year returns of EDIT is -92.10% as on 10 Oct '26.

What is the high & low stock price of EDIT today?

chevron-up
EDIT stock price hit a high of $2.97 and low of $2.73 as of 10 Oct '26.

Can I buy EDIT shares in India?

chevron-up
Yes. You can buy EDIT in India by opening an international trading account.